Descripción
🎥 Video Details 🎥
🌟 About This Video 🌟
OpenAI announced GPT-Rosalind, a biology-focused AI model released as a research preview for select U.S. enterprise users, underscoring rising competition in AI-driven drug discovery.
Built for complex workflows, GPT-Rosalind supports AI drug discovery, translational medicine, and experiment planning via ChatGPT, Codex, API, and a life sciences plugin.
It integrates more than 50 scientific data sources and tools, and posted top BixBench scores with expert-level RNA prediction.
Early access involves verified research organizations, including Amgen and Moderna, with safeguards to detect potential misuse such as bioweapons-related risks.
OpenAI said the system cannot independently create new treatments but can accelerate research, and biotech shares including Recursion Pharmaceuticals and Schrodinger fell after the announcement. #aiinbiotech #drugdiscovery #gptrosalind #lifesciences #openai
🤖 Crafted with Rizzle AI 🤖
This video was created using Rizzle AI, the ingenious no-edit video creation platform, with industry-leading assets from GettyImages and Soundstripe. Elevate your video content with Rizzle AI: https://app.rizzle.com/create
🔔 If you enjoyed this video, don't forget to like, share, and subscribe! 🔔